These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 5493532

  • 1. Inhibitors of the fibrinolytic enzyme system in renal disease.
    Bennett NB, Ogston D.
    Clin Sci; 1970 Nov; 39(5):549-57. PubMed ID: 5493532
    [No Abstract] [Full Text] [Related]

  • 2. Demonstration of low content of fibrinolytic inhibitors in individuals with high fibrinolytic capacity.
    Hedner U, Nilsson IM, Jacobsen CD.
    Scand J Clin Lab Invest; 1970 Jun; 25(4):329-36. PubMed ID: 4247664
    [No Abstract] [Full Text] [Related]

  • 3. On coagulation and fibrinolysis in renal failure.
    Larsson SO.
    Scand J Haematol Suppl; 1971 Jun; 15():1-59. PubMed ID: 5284430
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Serum and urinary lysozyme activities in patients with renal diseases.
    Niwa T, Ito T, Matsui E, Ota H.
    Tohoku J Exp Med; 1974 Sep; 114(1):27-33. PubMed ID: 4432241
    [No Abstract] [Full Text] [Related]

  • 6. Resting levels of fibrinolysis in blood in inactive and exercising men.
    Moxley TR, Brakman P, Astrup T.
    J Appl Physiol; 1970 May; 28(5):549-52. PubMed ID: 5442247
    [No Abstract] [Full Text] [Related]

  • 7. A clinical study on urinary kallikrein in patients with renal diseases.
    Kimura K, Onodera K, Oike Y, Yamabe H, Numahata H, Kikuchi K, Hanada S.
    Adv Exp Med Biol; 1979 May; 120B():549-59. PubMed ID: 517249
    [Abstract] [Full Text] [Related]

  • 8. [Urokinase excretion and fibrinolysis in infectious kidney diseases].
    Bachmann HJ, Tacke E, Haupt H.
    Monatsschr Kinderheilkd (1902); 1974 Jul; 122(7):567-8. PubMed ID: 4411414
    [No Abstract] [Full Text] [Related]

  • 9. [Additional potentials of a method of standard fibrin plates].
    Kovalenko AN.
    Lab Delo; 1980 Jul; (10):615-8. PubMed ID: 6158612
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Previously undescribed fibrinolysis inhibitor in human blood.
    Siegel-Ralston A, Astrup T.
    Nat New Biol; 1971 Dec 08; 234(49):180-1. PubMed ID: 4257614
    [No Abstract] [Full Text] [Related]

  • 12. Pattern of the activator inhibitor in carcinoma and renal diseases.
    Hedner U, Nilsson IM.
    Scand J Haematol; 1973 Dec 08; 11(5):398-404. PubMed ID: 4798342
    [No Abstract] [Full Text] [Related]

  • 13. [Characteristics of components of the fibrinolytic system in healthy children].
    Sofronova LV.
    Vopr Okhr Materin Det; 1975 Jun 08; 20(6):17-9. PubMed ID: 124506
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of plasminogen activators by naturally occurring inhibitors in man.
    Aoki N, Kawano T.
    Am J Physiol; 1972 Dec 08; 223(6):1334-7. PubMed ID: 4641625
    [No Abstract] [Full Text] [Related]

  • 18. Lactic dehydrogenase in kidney tissue and renal disease. Adaptive change of the synthesis in acute failure.
    Nielsen VK, Kemp E, Laursen T.
    Acta Med Scand; 1968 Dec 08; 184(1-2):109-19. PubMed ID: 5703958
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serum lipase activity in chronic renal failure.
    Sommer H, Kasper H, Fösel T.
    Acta Hepatogastroenterol (Stuttg); 1975 Aug 08; 22(4):248-52. PubMed ID: 1179947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.